Huge Sales Growth Brightens Future for Amarin Stock
There are still a lot of questions for Amarin must figure out before it gets back on track. For investors, the question is whether it is the market recovery that is lifting the stock…
All Work
Chris Lange
The Services Business Is Making Apple Stock a Safe Bet
Slumping iPhone sales and other near-term problems are being offset by Apple's incredible services business. If anything, this makes Apple quite a safe bet.
Will Cisco Systems Outperform Again in Q3?
Cisco Systems is scheduled to release its fiscal third-quarter financial results after the markets close on Wednesday. Will it beat low expectations?
Why Juul’s European Departure Helps Altria Stock
COVID-19 has already beaten up tobacco giant Altria but things may be getting even worse as Juul, in which it has a stake, is facing fresh problems.
Why This Funding Is Crucial for Novavax
Novavax shares jumped on Tuesday after the company announced that it would be receiving a sizable investment to further produce its COVID-19 vaccine.
What’s Next for CymaBay’s NASH Study
CymaBay Therapeutics shares more than doubled on Tuesday after the company announced its first-quarter results, along with a corporate update.
Cannabis Stocks See Rising Tide in Short Interest
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Short Sellers Raise the Stakes in Major Biotechs
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Is Semiconductor Short Interest Signaling an Overall Recovery?
The April 30 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
Why a Phased Restart Is Crucial to Ford Stock
This Detroit automaker needs to get back on track, and the only way they can do that is by restarting production in a safe but effective way before it falls to penny stock status.
Second Wave of Coronavirus Cases Has Investors Rethinking Cruise Ship Stocks
Across the board, cruise companies were tossed around on Monday amid concerns that a potential second wave of coronavirus infections could stifle business.
COVID-19 Testing Continues to Lift Aytu BioScience Stock
This specialty pharmaceutical company is making good progress on multiple fronts, including changes to its board of directors and with its test for and treatment of COVID-19.
Why MyoKardia’s Late-Stage Hypertophric Cardiomyopathy Study Is a Big Hit
MyoKardia shares made an incredible gain on Monday after the company announced positive results from its late-stage pivotal clinical trial of mavacamten.
How a Reopening of Shanghai Will Help Disney Stock
Shanghai Disneyland is reopening, and this may provide the first indications of how Walt Disney will fare a post-COVID-19 world.
Why Cellect Biotech’s Bone Marrow Transplantation Update Is Huge
Cellect Biotechnology shares nearly doubled to start the week after the company announced progress with its bone marrow transplantation process.
How Much Trouble Is Marriott Stock in After Q1?
Marriott International shares fell to a new 52-week low after it reported its first-quarter financial results before the opening bell on Monday.
Applied Materials, Cisco, Mylan, Under Armour and More Earnings Due This Week
24/7 Wall St. has put together a preview of Applied Materials, Cisco, Norwegian Cruise Line and some of the other most anticipated quarterly reports due this week.
Gilead Sciences Gains Remdesivir Approval in Japan
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment.
Why Services Will Push Apple Stock to the Next Level
The recent quarterly results have proved that services will be a huge driving force for Apple in the years to come. The business is fairly insulated against the pandemic, too.
Will Cost-Cutting Measures Keep Lyft Stock Afloat?
Lyft is playing a defensive game, cutting costs and restructuring, but will be enough to keep the company afloat in these trying economic times?